Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Salim S Virani

Showing results (1-10 of 785) with videos related to

Pageof 79
Sort By:
JAMA Network Open|August 23, 2022
Statins and Primary Atherosclerotic Cardiovascular Disease Prevention-What We Know, Where We Need to Go, and Why Are We Not There Already?Salim S Virani
Texas Heart Institute Journal|April 16, 2011
Non-HDL cholesterol as a metric of good quality of care: opportunities and challengesSalim S Virani
Texas Heart Institute Journal|August 23, 2016
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial ComponentsSalim S Virani
The New England Journal of Medicine|November 7, 2022
The Fibrates Story - A Tepid End to a PROMINENT DrugSalim S Virani
Texas Heart Institute Journal|August 6, 2013
Statins in the primary and secondary prevention of cardiovascular disease in women: facts and mythsSalim S Virani
Texas Heart Institute Journal|June 29, 2012
Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directionsSalim S Virani
Texas Heart Institute Journal|June 24, 2014
What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults?Salim S Virani
Journal of Medical Economics|April 9, 2020
Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit?Dhruv Mahtta, Salim S Virani
Journal of the American Heart Association|March 30, 2019
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?Xiaoming Jia, Salim S Virani
Texas Heart Institute Journal|October 31, 2018
Lipid-Lowering Therapies: Risks in Women and Evidence-Based OptionsTina Shah, Salim S Virani
Pageof 79

Showing results (1-10 of 785) with videos related to

Sort By:
Pageof 79
JAMA Network Open|August 23, 2022
Statins and Primary Atherosclerotic Cardiovascular Disease Prevention-What We Know, Where We Need to Go, and Why Are We Not There Already?Salim S Virani
Texas Heart Institute Journal|April 16, 2011
Non-HDL cholesterol as a metric of good quality of care: opportunities and challengesSalim S Virani
Texas Heart Institute Journal|August 23, 2016
The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial ComponentsSalim S Virani
The New England Journal of Medicine|November 7, 2022
The Fibrates Story - A Tepid End to a PROMINENT DrugSalim S Virani
Texas Heart Institute Journal|August 6, 2013
Statins in the primary and secondary prevention of cardiovascular disease in women: facts and mythsSalim S Virani
Texas Heart Institute Journal|June 29, 2012
Implementation strategies to improve non-HDL-cholesterol goal attainment: current evidence and a conceptual framework for future directionsSalim S Virani
Texas Heart Institute Journal|June 24, 2014
What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults?Salim S Virani
Journal of Medical Economics|April 9, 2020
Novel antithrombotic regimen in patients with ischemic heart disease and peripheral arterial disease: can we identify those who derive the highest benefit?Dhruv Mahtta, Salim S Virani
Journal of the American Heart Association|March 30, 2019
CLEAR Serenity Trial: More Clarity for the Future of Bempedoic Acid in Patients Unable to Take Statins?Xiaoming Jia, Salim S Virani
Texas Heart Institute Journal|October 31, 2018
Lipid-Lowering Therapies: Risks in Women and Evidence-Based OptionsTina Shah, Salim S Virani
Pageof 79